Biotechnology European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer’s Drug Lecanemab Why Is Biogen Stock Falling Friday? – Biogen (NASDAQ:BIIB) Read more
Biotechnology IGC Pharma Advances In Alzheimer’s Research From Pre-clinical Studies To Phase Two Trials With Its Novel Therapy Candidate IGC-AD1 – IGC Pharma (AMEX:IGC) Read more
Biotechnology Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD 2024 International Conference – Athira Pharma (NASDAQ:ATHA) Read more
Stockmarkets INmune Bio reports EEG improvement in Alzheimer’s therapy By biedexmarkets.com Read more
Biotechnology Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B – Biotech’s Investigational Alzheimer’s Treatment Shows Positive Trial Results – Longeveron (NASDAQ:LGVN) Read more
Biotechnology UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst – Axsome Therapeutics (NASDAQ:AXSM) Read more
Stockmarkets Exclusive-Eisai expects 1,500 Alzheimer’s patients in China launch, sees ‘huge’ growth Reuters via biedexmarkets.com Read more
Biotechnology Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer’s, Shifts Focus On Newer Medicines – Biogen (NASDAQ:BIIB) Read more